MedTrace Logo

Assessing Cognitive Performance Among Adults With Attention Disorders Working on Treadmill

NCT05243186 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-03-31

No results posted yet for this study

Summary

Randomized clinical trial in which individuals who have been diagnosed with ADHD and are regularly treated with Methylphenidate will be test for cognitive performance and will be randomly examined in the following four conditions:

* While taking Methylphenidate and sitting at a desk
* While taking Methylphenidate and walking on a treadmill workstation
* Without taking Methylphenidate while sitting at a desk
* Without taking Methylphenidate while walking on a treadmill workstation The investigators will compare the cognitive achievements outcomes and evaluate the efficiency of studying in each of these four conditions.

Conditions

  • Attention Deficit Disorder

Interventions

DEVICE

Treadmill workstation

walking on a treadmill workstation next to desk with computer and screen

DRUG

Methylphenidate

Using prescription drug

Sponsors & Collaborators

  • Maccabi Healthcare Services, Israel

    collaborator OTHER

  • Ariel University

    lead OTHER

Principal Investigators

  • Liat Korn, PhD · Ariel University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-07-31
Completion
2022-10-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05243186 on ClinicalTrials.gov